Cargando…

Correction: Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Miscellaneous
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456548/ https://www.ncbi.nlm.nih.gov/pubmed/32816784 http://dx.doi.org/10.1136/annrheumdis-2020-216980corr1

Ejemplares similares

Correction: Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging study
Publicado: (2021)

Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
por: van der Heijde, Désirée, et al.
Publicado: (2020)

Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020)

Neutrophil Extracellular Traps and Interleukin 17 in Ankylosing Spondylitis
por: Papagoras, Charalampos, et al.
Publicado: (2021)

Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells
por: Shah, Mittal, et al.
Publicado: (2020)

Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis
por: He, Tao, et al.
Publicado: (2017)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
por: Girbash, Ehab F., et al.
Publicado: (2023)

Effectiveness of interleukin-17A inhibitors in patients with ankylosing spondylitis: A protocol for systematic review and meta-analysis
por: Yan, Mingguang, et al.
Publicado: (2022)

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation
por: Glatt, Sophie, et al.
Publicado: (2018)

Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials
por: Wang, Peng, et al.
Publicado: (2021)

Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis
por: Yeremenko, Nataliya
Publicado: (2021)

Correction: Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis
Publicado: (2021)

Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
por: Chen, Bingni, et al.
Publicado: (2015)

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients
por: Lemancewicz, Dorota, et al.
Publicado: (2012)

Interleukin-17A and interleukin-23 in morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2012)

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
por: van der Heijde, Désirée, et al.
Publicado: (2017)

Association of genetic polymorphism of interleukin-17A & interleukin-17F with susceptibility of psoriasis
por: Kaur, Rajinder, et al.
Publicado: (2018)

Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease
por: Krawiec, Paulina, et al.
Publicado: (2020)

Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19(+) B cells in patients with ankylosing spondylitis
por: Zhang, Yu, et al.
Publicado: (2022)

Targeting interleukin-17 receptors
por: Lee, Wen-Hwa, et al.
Publicado: (2015)

Roles of interleukin-17 in uveitis
por: Guedes, Marta Catarina Esteves, et al.
Publicado: (2016)

Interleukin-17 in Antifungal Immunity
por: Sparber, Florian, et al.
Publicado: (2019)

Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
por: Yan, Ai, et al.
Publicado: (2022)

Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity
por: Ugur, Mahir, et al.
Publicado: (2015)

High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation
por: Lee, Eun-Ju, et al.
Publicado: (2015)

New insights into IL-17/IL-23 signaling in ankylosing spondylitis (Review)
por: Chisălău, Beatrice Andreea, et al.
Publicado: (2020)

Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia
por: Chenniappan, Raghavi, et al.
Publicado: (2020)

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis
por: Zhang, Hui, et al.
Publicado: (2021)

Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F
por: Adams, Ralph, et al.
Publicado: (2020)

Aberrant expression of interleukin-23-regulated miRNAs in T cells from patients with ankylosing spondylitis
por: Lai, Ning-Sheng, et al.
Publicado: (2018)

Interleukin-17 in human inflammatory diseases
por: Shabgah, Arezoo Gowhari, et al.
Publicado: (2014)

Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014)

The Role of Interleukin-17 in Lung Cancer
por: Wu, Feng, et al.
Publicado: (2016)

Interleukin-17A and Keratinocytes in Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2020)

Role of Interleukin-17 in Acute Pancreatitis
por: Li, Guanqun, et al.
Publicado: (2021)

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
por: Hammitzsch, Ariane, et al.
Publicado: (2018)

Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients
por: DEVECI, HULYA, et al.
Publicado: (2020)

Interleukin – 17 and Interleukin-10 as Inflammatory and Prevention Biomarkers in Periimplant Diseases
por: Farhad, Shirin Zahra, et al.
Publicado: (2019)

Analysis of interleukin-17 and interleukin-18 levels in animal models of atherosclerosis
por: Tang, Xiuming
Publicado: (2019)

Interleukin-17 and type 17 helper T cells in cancer management and research
por: Llosa, Nicolas J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_61qp3v8ip71g6lanibrmhnah1b